| 441 |
Urinary tissue factor (uTF), tissue factor pathway inhibitor (TFPI) and plasmin as novel biomarkers in early diagnosis of lupus nephritis. |
Internal Medicine |
2024 |
| 442 |
Use of mesenchymal stem cells in Experimental Ovarian Damage |
Department of Medical Physiology |
2024 |
| 443 |
Validation of the AO Spine CROST (Clinician Reported Outcome Spine Trauma) in the clinical setting |
Department of Orthopedic Surgery and Traumatology |
2024 |
| 444 |
Validation of the arabic version of the EuroQol-5-dimension 5-level (EQ-5D-5 L) in patients with spinal degenerative diseases |
Department of Orthopedic Surgery and Traumatology |
2024 |
| 445 |
Value of aspartate aminotransferase/alanine aminotransferase Ratio in predicting coronary thrombus burden in ST elevation myocardial infarction patients undergoing primary percutaneous coronary intervention |
Internal Medicine |
2024 |
| 446 |
Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligation-induced hepatopulmonary syndrome in rat |
Department of Pharmacology |
2024 |
| 447 |
Vildagliptin ameliorates intrapulmonary vasodilatation and angiogenesis in chronic common bile duct ligationinduced hepatopulmonary syndrome in rat |
Department of Gastroenterology and Tropical Medicine |
2024 |
| 448 |
Vitamin D level and its association with disease activity in Egyptian Rheumatoid Arthritis patients. |
Internal Medicine |
2024 |
| 449 |
Vitamin-K antagonist versus dual antiplatelet therapy in management of isolated and non-obstructive atherosclerotic coronary artery ectasia |
|
2024 |
| 450 |
Vitamin-K antagonist versus dual antiplatelet therapy in management of isolated and non-obstructive atherosclerotic coronary artery ectasia. |
|
2024 |
Do you have any questions? 
